Tag

Journal of Drugs in Dermatology

SOCU Faculty Research: Thiamidol for Hyperpigmentation

By Skin of Color Update Agenda

hyperpigmentation

Skin of Color Update faculty are experts in skin of color dermatology. Eight faculty members were involved with this recent Journal of Drugs in Dermatology article on Thiamidol as a treatment for hyperpigmentation.

Drs. Cheri Frey, Pearl Grimes, Valerie Callender, Andrew Alexis, Hilary Baldwin, Nada Elbuluk, Susan Taylor, and Seemal Desai conducted the review of pre-clinical and clinical safety and efficacy data of Thiamidol formulations. Thiamidol or isobutylamido thiazolyl resorcinol, has been identified as the most effective human tyrosinase inhibitor out of 50,000 compounds screened. The researchers wrote that Thiamidol appears to be safe and effective and should be considered when recommending over-the-counter treatment options to patients with hyperpigmentation.

For the latest research and updates in the treatment of hyperpigmentation, attend Skin of Color Update. Register today!

JDD Video Abstract with Dr. Cheri Frey

By Aesthetic Dermatology

pre-aging

Skin of Color Update faculty member Cheri Frey, MD, FAAD, recently shared a video abstract of her Journal of Drugs in Dermatology study evaluating the benefits of acetyl dipeptide-31 amide (AP31) for pre-aging skin.

Watch as Dr. Frey outlines the signs of pre-aging and the goal of prejuvenation. Learn how Dr. Frey and her colleagues conducted their research on AP31 and their results. Find out her takeaways and how dermatologists are now addressing aging skin before changes are visible.

Dr. Frey will lecture on cosmeceuticals and exosomes at Skin of Color Update. Register today!